Skip to content
Clinical Trials – home

Find therapies in clinical trials near you – page 153

recruiting
3 974
countries
28
conditions
2 109

10 386 trials match your criteria

Study Comparing Electrochemotherapy with Bleomycin to Standard Radiotherapy for Treating Basal Cell Carcinoma in Patients with Tumors Less Than 3 cm

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years

Neuroblastoma

Recruiting

Study of GD2-CAR T Cells, Cyclophosphamide, and Fludarabine for Children with High-Risk or Relapsed Neuroblastoma and Other GD2+ Tumors

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Rimiducid

Study on the Effects of Full Spectrum Cannabis Extract (Dronabinol, Cannabidiol) for Patients with Hard-to-Treat Epilepsy in Tuberous Sclerosis Complex

Investigational
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years

Study of Mesenchymal Stromal Cells Treatment for Patients with Traumatic Brain Injury: A Safety and Effectiveness Trial

InvestigationalNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years

Naevus flammeus

Recruiting

Study on the Effects of Sirolimus Cream for Patients with Port Wine Stains

Registered drug
Countries:SpainSpain
  • Participants:0–17 years · 18–64 years

Pterygium

Recruiting

Study on Fibrin Matrix and Autologous Growth Factor Eye Drops for Pterygium Surgery Patients

InvestigationalNo placebo
Countries:SpainSpain
  • Participants:18–64 years

Study Comparing Isoflurane and Propofol for Sedation in Critically Ill Patients on Mechanical Ventilation

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study on Toripalimab and Tifcemalimab for Patients with Limited-Stage Small Cell Lung Cancer After Chemoradiotherapy

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Tifcemalimab

Study on Luspatercept for Treating Anemia in Patients with Myelodysplastic Syndromes (MDS) with del5q, Resistant to Prior Treatments and Needing Blood Transfusions

Registered drugNo placebo
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Luspatercept

Study Comparing Two Amiodarone Doses to Maintain Heart Rhythm in Patients with Persistent Atrial Fibrillation After Cardioversion

Registered drugNo placebo
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Study on Fecal Microbiome Transplantation for Patients with Decompensated Cirrhosis Using Allogeneic Fecal Microbiota Capsules

Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years

Title: Study of vedolizumab dose adjustment guided by drug level monitoring in patients with inflammatory bowel disease in remission

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Vedolizumab
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.